Privia Health
Organizes physician practices with technology, administration, and value-based-care infrastructure.
Something off on this page? Send us feedback.
Profile
Organizes community physician practices into regional medical groups and value-based-care networks, supplying technology, administration, payer contracting, and population-health services. Revenue comes from fee-for-service care and administration, capitation, shared savings, care-management fees, and ancillary services, while many affiliated practices remain physician-owned.
Organizes independent physicians and clinicians into regional, primary-care-centric networks through Privia Medical Group, while Privia Care Partners connects practices seeking only value-based-care support. Across U.S. markets, the Privia Platform combines workflow technology with revenue-cycle management, payer contracting, analytics, and practice operations.
Earns fee-for-service patient-care and administrative revenue, plus capitation, shared savings, care-management fees, and ancillary-service revenue. Local physician governance and continued practice ownership preserve clinical autonomy, while centralized medical groups, management-services organizations, and accountable care organizations coordinate reimbursement and population health.
Some medical groups are owned or consolidated; others are served under management agreements or state-specific friendly-physician structures. The model depends on provider affiliations, payer and health-system relationships, government reimbursement programs, healthcare and privacy rules, and an athenahealth-based electronic medical record.
Company facts
Key statistics
Year to date −11.5% · Average volume (30d) 1.1M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 7, 2026 | Canaccord Genuity | Target | $34 | $32 | |
| May 26, 2026 | Barclays | Reiterate | Equal Weight | $22 | $24 |
| Apr 8, 2026 | Evercore ISI | Target | $22 | $26 | |
| Feb 26, 2026 | Jefferies | Target | $32 | ||
| Feb 26, 2026 | Piper Sandler | Target | $40 | $36 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026Q2 FY26 | $0.07 | $0.07 | +3.9% | $597.3M | $632.6M | +5.9% | −8.18% |
| May 7, 2026Q1 FY26 | $0.08 | $0.02 | −75.0% | $561.0M | $603.8M | +7.6% | −3.88% |
| Feb 26, 2026Q4 FY25 | $0.04 | $0.07 | +75.0% | $516.2M | $541.2M | +4.8% | −4.66% |
| Nov 6, 2025Q3 FY25 | $0.06 | $0.05 | −16.7% | $516.6M | $580.4M | +12.4% | −2.29% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $480.1M | $521.2M | $580.4M | $541.2M | $603.8M | $632.6M | |
| Gross profit | $45.8M | $47.7M | $61.0M | $49.7M | $57.0M | $11.8M | |
| Operating income | $5.2M | $3.3M | $14.4M | $11.3M | $7.4M | $11.8M | |
| Net income | $4.2M | $2.7M | $6.9M | $9.2M | $3.1M | $9.0M | |
| Diluted EPS | $0.03 | $0.02 | $0.05 | $0.07 | $0.02 | $0.07 | |
| Gross margin | 9.5% | 9.1% | 10.5% | 9.2% | 9.4% | 1.9% | |
| Operating margin | 1.1% | 0.6% | 2.5% | 2.1% | 1.2% | 1.9% |
Fiscal years (4-quarter sums)FY21 $966.2M · FY22 $1.36B · FY23 $1.66B · FY24 $1.74B · FY25 $2.12B
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $412.20B · Total debt $8.73B · Total assets $1.49T · Shareholders' equity $782.33B
Dividends
No dividends on record.
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 126.01M · Float 113.23M · 89.9% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 21.40M | 16.98% | 13F | Aug 7, 2026 |
| FMR LLC | 12.85M | 10.20% | 13F | Aug 13, 2026 |
| Durable Capital Partners LP | 11.64M | 9.23% | 13F | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 6.57M | 5.22% | 13F | Aug 13, 2026 |
| Rubicon Founders LLC | 5.97M | 4.74% | 13F | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jul 9, 2026 | David Mountcastle | officer: EVP & Chief Financial Officer | −21,275 | $27.67 |
| Jul 7, 2026 | David Mountcastle | officer: EVP & Chief Financial Officer | −600 | $27.57 |
| Jul 2, 2026 | David Mountcastle | officer: EVP & Chief Financial Officer | −24,734 | $27.50 |
| Jul 6, 2026 | Matthew Shawn Morris | director | −53,722 | $27.24 |
| Jul 2, 2026 | Matthew Shawn Morris | director | −59,037 | $27.33 |
Peers
- Agilon Health
Physician enablement and MA value-based care peer.
- Astrana Health
Provider-centric VBC and care-enablement platform.
- UnitedHealth Group
Optum scale competitor in VBC and provider services.
- Humana
CenterWell senior primary-care and VBC MSO rival.
- CVS Health
Oak Street and Signify overlap in value-based care.
- P3 Health Partners
Physician-led MA population-health competitor.
- Evolent
Adjacent specialty-care VBC infrastructure peer.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Privia Health | $20.79 | +0.10% | $2.62B | 95.9 | 54.4 | 1.1 | +21.4% |
| Agilon Health | $92.54 | −0.02% | $1.54B | — | — | 0.3 | +7.2% |
| Astrana Health | $37.96 | 0.00% | $1.88B | 46.4 | 23.6 | 0.5 | +48.5% |
| UnitedHealth Group | $392.50 | −0.12% | $356.86B | 25.3 | 18.4 | 0.8 | +0.4% |
| Humana | $386.23 | +0.16% | $46.30B | 36.5 | 31.2 | 0.3 | +26.2% |
| CVS Health | $93.07 | +0.02% | $118.74B | 24.6 | 11.5 | 0.3 | +7.3% |
| P3 Health Partners | $9.22 | −0.43% | $30.2M | — | — | 0.0 | +8.6% |
| Evolent | $4.58 | −0.22% | $517.4M | — | 13.6 | 0.2 | +46.9% |
| Median | 30.9 | 18.4 | 0.3 | +8.6% |